Industry Newsmanaged caresurgery partnershealthcare equitiesanalyst ratings
Surgery Partners Garners Bullish Analyst Outlook
6.0
Mizuho Securities analyst Ann Hynes reiterated a Buy rating on Surgery Partners (NASDAQ:SGRY) on December 18, assigning a $19 price target, implying about 21% upside from current levels. Hynes cited a projected managed-care turnaround in 2026 that could improve Medicaid and Medicare margins; the stock has 11 analyst coverage with a consensus target of $26.30, implying roughly 67.5% upside.
Key Points
- 1Reiterates buy rating with $19 price target, implying 21% upside from current levels
- 2Cites managed-care 2026 turnaround ending three-year underwriting cycle, improving Medicaid and Medicare margins
- 3Suggests potential earnings and margin expansion for Surgery Partners benefiting non-emergency surgical services
Scoring Rationale
Analyst-backed, credible coverage provides actionable investment signals; limited novelty and limited relevance outside healthcare equities.
Sources
Public references used for this report.
Practice with real Health & Insurance data
90 SQL & Python problems · 15 industry datasets
Used by DS/ML engineers at top companies
250 free problems · No credit card
See all Health & Insurance problems
